Nutrimed Labs: FIBROMYALGIA

Condition: FIBROMYALGIA

SUGGESTED NUTRITION:

ATP Plus #495
1 capsule - 3 times per day. A formula containing both magnesium hydroxide and malic acid.

Thyro Complex #839
1 capsule - 3 times per day. A glandular product containing Thyroid concentrate, Adrenal Concentrate, Pituitary Concentrate and Spleen concentrate.

Co-Enzyme Q-10, 100 mg. with Vitamin E #K741
1 - 2 Chewable tables (walnut flavored> CoQ-10 is essential in the formation of ATP in the mitochondria of each and every cell of the human body.

To order any of these products, click the blue link and use our online shopping cart. All of our products are manufactured in a US FDA approved facility.

PATHOLOGICAL CONSIDERATIONS:

Fibromyalgia exhibits many of the same symptoms as Chronic Fatigue Syndrome. Both conditions reveal reduced diurnal glucocorticoid levels, impaired reactivity of the hypothalamic-pituitary-adrenal axis, and reduced ATP production. Biopsies condicted on FMS patients indicate mitochondrial damage in the muscle, a metabolic abnormality. An impairment in glycolysis leads to an energy crisis with abnormal carbohydrate metabolixm and phosphorylation, causing failure of thiamin activation and serotonin depletion. Bood chemistry findings of FMS patients typically show: LOW thiamin activation, Serotonin, Growth Hormone, High-Energy Phosphates (ATP in Red Blood Cells, Lactic Dehydrogenase, Phosphocreatinine/inorganic Phosphates, Phosphate/Creatinine/ATP, Magnesium (RBC), Tryptophan (plasma), Histidine and Serine (plasma), Cortisol, DHEAS, NADP (RBC), Serum Serotonin, Norephinephrine and Dopamine (in cerebrospinal fluid). HIGH: Pyruvate, Pyruvate/Lactate, Quinolinic Acid, Substance P.

PHYSIOLOGICAL CONSIDERATIONS:

A rheumatic condition characterized by wisespread, migrating, and often debilitating pain and fatigue which prevent the patient from accomplishing everyday tasks. Presently, no laboratory test can definitively identify a patient with FMS. Disgnosis is difficult since many other diseaseS and conditions also present similar symptoms. However, two criteria define the syndrome: (1) Widespread musculoskeletal pain in all four quadrants of the body for at least three months, in combination with (2) Tenderness at 11 or more 18 specific tender points sites.

TREATMENT:

FMS patients have a marked impairment of thiamin status, which responds better to thiamin pyrophosphate than thiamin hydrochloride. Injectable thiamin may have a beneficial effect. Thiamin-dependant enzymes also require adequate magnesium. Remarkable results have been attained using a combination of 300-600 mg of magnesium hydroxide and 1200-1400 mg. of malic acid per day. Both magnesium and malic acid play a role in aerobic and anaerobic reactions leading to the production of ATP. Because both substances have an oxygen-sparing effect, a deficiency of either possibly can induce the hypoxia common in the muscles of FMS patients.

Related Newsletter: FIBROMYALGIA - THE REAL STORY